Skip to product information
1 of 1

Sytrinol® LNA

Sytrinol® LNA

As an alternative to statins, it leverages the synergy of leucine and nicotinic acid with polymethoxylated flavones and tocotrienols to improve lipid biomarkers, fat oxidation, antioxidant pathways and circadian rhythms. This axis between
SIRT1/NAD+/AMPK is the focus of Sytrinol® LNA and its ability to improve metabolism and dyslipidemia.
Regular price $99.00 USD
Regular price $0.00 USD Sale price $99.00 USD
Sale Sold out
Shipping calculated at checkout.
View full details


Sytrinol® 300 mg

+ Nobiletin: Tangerentin 270 mg

+ Tocotrienols 30 mg

• Leucine 1,100 mg

• Nicotinic Acid 75 mg

  • A patented combination of polymethoxylated flavones and tocotrienols.

  • Sytrinol was shown to have a positive effect on TG, LDL and ApoB

  • Low dose leucine was found to decrease nicotinic acid dose by 95% and still get same therapeutic outcomes.

  • Nobelitin was shown to increase hepatic fatty acid oxidation, decrease fatty acid synthesis and decrease inflammatory gene transcription factors.

Means + SEM. Statistical analysis by ANOVA plus post test by Dunnett’s method

b- Significantly different within same group, P ≤ 0.05

Source: SourceOne Global Partner